rus
Issue #2/2020
R.F.Kapustin, М.B.Tarasov, I.P.Pogorelsky, V.I.Khachko, S.I.Tsybulnikov
Biosafety of nanodrugs used in livestock and poultry breeding
Biosafety of nanodrugs used in livestock and poultry breeding
DOI: 10.22184/1993-8578.2020.13.2.150.156
The use of nanotechnologies enabled the creation of products: Sky-Force, Pentacycline, Rifomast and Endosuper having previously unattainable properties. New properties and methods for producing new materials are determined by the unique properties of nanoparticles and the peculiarities of handling with them.
The use of nanotechnologies enabled the creation of products: Sky-Force, Pentacycline, Rifomast and Endosuper having previously unattainable properties. New properties and methods for producing new materials are determined by the unique properties of nanoparticles and the peculiarities of handling with them.
Теги: bacteria biosafety certification histological studies identification nanodrugs selective exposure therapeutic efficacy viruses бактерии биобезопасность вирусы гистологические исследования нанопрепараты селективное воздействие сертификация терапевтическая эффективность
Biosafety of nanodrugs used in livestock and poultry breeding
The developing antibiotic resistance, the appearance of superbugs resistant to a number of antibacterial agents made it necessary to create chemotherapeutic agents (CTA) of a fundamentally new class. The use of nanotechnologies enabled the creation of market products such as M. Tarasov’s nanodrugs: Sky-Force, Pentacycline, Rifomast and Endosuper having previously unattainable properties. New properties of a substance, methods for producing new materials obtained on the basis of new technical solutions are determined by the unique properties of nanoparticles and the peculiarities of handling with them (nanotechnologies).
It is proven that in order to obtain a certificate of conformity for unique drugs, it is sufficient to unambiguously identify the final product with a 100% probability. Studies on the application of histological control for pork products have proved the biosafety of nanostructured drugs.
The effectiveness of the Sky-Force nanostructured drug with regard to pathogens of dangerous infections (brucellosis and African Swine Fever – ASF) is revealed. The uniqueness of the nanostructured drug properties is experimentally proved, which implies the additional development of instrumental methods for the final quality inspection of the nanodrugs themselves. The biosafety requirements for nanostructured drugs shall be laid down in the technical assignment when developing nanostructures with tailor-made physicochemical and therapeutic properties. The conducted histological studies of the finished livestock and poultry products allow us to reliably inspect the compliance of the nanostructured drugs used for therapeutic purposes with the biosafety requirements. The lack of data on the starting ingredients, on the basis of which the nanodrugs were created, makes certification of the latter difficult. It is shown that for reliable certification of nanostructured drugs, instrumental methods of examining for their compliance with reference samples are sufficient.
The developing antibiotic resistance, the appearance of superbugs resistant to a number of antibacterial agents made it necessary to create chemotherapeutic agents (CTA) of a fundamentally new class. The use of nanotechnologies enabled the creation of market products such as M. Tarasov’s nanodrugs: Sky-Force, Pentacycline, Rifomast and Endosuper having previously unattainable properties. New properties of a substance, methods for producing new materials obtained on the basis of new technical solutions are determined by the unique properties of nanoparticles and the peculiarities of handling with them (nanotechnologies).
It is proven that in order to obtain a certificate of conformity for unique drugs, it is sufficient to unambiguously identify the final product with a 100% probability. Studies on the application of histological control for pork products have proved the biosafety of nanostructured drugs.
The effectiveness of the Sky-Force nanostructured drug with regard to pathogens of dangerous infections (brucellosis and African Swine Fever – ASF) is revealed. The uniqueness of the nanostructured drug properties is experimentally proved, which implies the additional development of instrumental methods for the final quality inspection of the nanodrugs themselves. The biosafety requirements for nanostructured drugs shall be laid down in the technical assignment when developing nanostructures with tailor-made physicochemical and therapeutic properties. The conducted histological studies of the finished livestock and poultry products allow us to reliably inspect the compliance of the nanostructured drugs used for therapeutic purposes with the biosafety requirements. The lack of data on the starting ingredients, on the basis of which the nanodrugs were created, makes certification of the latter difficult. It is shown that for reliable certification of nanostructured drugs, instrumental methods of examining for their compliance with reference samples are sufficient.
Readers feedback
